The formation of
protease-resistant
prion protein (
PrP-res or PrP(Sc)) involves selective interactions between
PrP-res and its normal
protease-sensitive counterpart,
PrP-sen or PrP(C). Previous studies have shown that synthetic
peptide fragments of the PrP sequence corresponding to residues 119-136 of hamster PrP (Ha119-136) can selectively block
PrP-res formation in cell-free systems and
scrapie-infected tissue culture cells. Here we show that two other
peptides corresponding to residues 166-179 (Ha166-179) and 200-223 (Ha200-223) also potently inhibit the
PrP-res induced cell-free conversion of
PrP-sen to the
protease-resistant state. In contrast, Ha121-141, Ha180-199, and Ha218-232 were much less effective as inhibitors. Mechanistic analyses indicated that Ha166-179, Ha200-223, and
peptides containing residues 119-136 inhibit primarily by binding to
PrP-sen and blocking its binding to
PrP-res. Circular dichroism analyses indicated that Ha117-141 and Ha200-223, but not non-inhibitory
peptides, readily formed high beta-sheet structures when placed under the conditions of the
conversion reaction. We conclude that these inhibitory
peptides may mimic contact surfaces between
PrP-res and
PrP-sen and thereby serve as models of potential therapeutic agents for
transmissible spongiform encephalopathies.